期刊文献+

壳聚糖递送的结核基因疫苗诱导的肺部黏膜免疫及在抗结核免疫保护中的意义 被引量:2

The mucosal immunity induced by chitosan-delivered gene vaccine and its significance in protection against tuberculosis
原文传递
导出
摘要 诱导肺局部黏膜免疫对于早期控制结核分枝杆菌(Mycobacterium tuberculosis)十分关键。在我们过去构建的结核基因疫苗pHSP65pep有效诱导脾脏IFN-γ+Th1细胞应答的基础上,为更好诱导呼吸道和肺局部黏膜免疫,采用天然生物多糖壳聚糖(chitosan)作为黏膜递送介质递送结核基因疫苗。制备壳聚糖-pHSP65pep结核黏膜疫苗,滴鼻免疫BALB/c小鼠,检测全身和黏膜T细胞免疫及抗体应答;并以大剂量BCG攻毒,以肺脏HE染色及菌落计数检测免疫保护效果。结果显示,壳聚糖黏膜递送虽不能增加血清HSP65特异性IgG抗体产生,但显著提高了肺灌洗液的SIgA水平;同时显著增强了肺黏膜局部pHSP65pep疫苗诱导的IFN-γ+CD4+Th1细胞应答。攻毒结果证实,壳聚糖递送显著增强了结核基因疫苗的免疫保护效果。表明壳聚糖黏膜递送可显著增强结核基因疫苗诱导的特异性肺黏膜Th1应答和SIgA水平,提高免疫保护效果。提示呼吸道黏膜免疫对于结核保护性免疫具有关键意义。 Induction of local(pulmonary) mucosal immunity plays a critical role in preventing Mycobacterium tuberculosis(M.tb) dissemination at the early infection stage.On the basis of our previously constructed muti-T-epitope DNA vaccine-pHSP65pep which effectively induced splenic IFN-γ+ Th1 response,chitosan,a natural cationic polysaccharide was employed as mucosal delivery media to enhance the specific mucosal immunity.The pHSP65-pep DNA was complexed with chitosan,and intranasally administered to BABL/c mice four times,using naked gene vaccine as control.Systemic and mucosal T cells response as well as antibody response was followed,and after challenging mice with lethal dose of BCG,the protection was evaluated by assessing H E staining of lung tissue and local bacterial loads.It was found that chitosan delivery did not change the specific serum IgG antibody induction,but significantly enhanced SIgA level in the lung lavage(P0.05).Chitosan significantly increased pulmonary CD4+ IFN-γ+ and CD8+ IFN-γ+ T cell frequency induced by pHSP65pep,which was much higher than the splenic counterpart(P0.05);Better protection was achieved by chitosan-pHSP65pep immunization as compared with naked gene vaccine.Our study indicated that chitosan delivery remarkably strengthened gene vaccine-induced specific mucosal Th1 response and SIgA level which was positively correlated with immunological protection against M.tb,and local mucosal immunity is very critical for the protection against M.tb infection.
出处 《现代免疫学》 CAS CSCD 北大核心 2011年第2期93-100,共8页 Current Immunology
基金 国家自然科学基金资助项目(30772020 81072409) 上海市科委基础重点项目(10JC1400900) 教育部留学回国基金(徐薇) 国家十一五重大专项(2008ZX10003011 2008ZX10003013-02)
关键词 结核 基因疫苗 黏膜免疫 壳聚糖 SIGA Mycobacterium tuberculosis mucosal immunity chitosan SIgA gene vaccine
  • 相关文献

参考文献29

  • 1Dye C. Global epidemiology of tuberculosis[J]. Lancet, 2006, 367:938- 940.
  • 2Flannagan RS, Cosio G, Grinstein S. Antimicrobial mecha nisms of phagocytes and bacterial evasion strategies[J]. Nat Rev Microbiol, 2009,7 : 355-366.
  • 3Young DB, Perkins MD, Duncan K, et al. 3rd. Confronting the scientific obstacles to global control of tuberculosis[J]. J Clin Invest, 2008,118:1255-1265.
  • 4Gao H, Yue Y, Hu L, et al. A novel DNA vaccine containing multiple TB specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmona ry mycobacterial challenge[J]. Vaccine, 2009,27:5313-5319.
  • 5Santosuosso M, McCormick S, Roediger E, et al. Mucosal luminal manipulation of T cell geography switches on protective efficaey by otherwise ineffeetive parenteral genetic immunization[J].J Immunol, 2007,178:2387 2395.
  • 6Kaufmann SH. Tuberculosis: back on the immunologists' agenda[J]. Immunity, 2006,24 : 351-357.
  • 7Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge[J]. Nat Rev Immunol, 2006,6:148-158.
  • 8Amidi M, Mastrobattista E, Jiskoot W, et al. Chitosambased delivery systems for protein therapeutics and antigens[J]. Adv Drug Deliv Rev,62:59-82.
  • 9Amidi M, Romeijn SG, Borchard G, et al. Preparation and characterization of protein-loaded N trimethyl chitosan nano- particles as nasal delivery system [J].J Control Release, 2006,111:107-116.
  • 10Mao S, Sun W, Kissel T. Chitosan-based formulations for delivery of DNA and siRNA[J].Adv Drug Deliv Rev, 2010, 62:12 27.

二级参考文献12

  • 1[1]Zhang T,Tang S,Jun G,et al.Persistent problems of access to appropriate,affordable TB services in rural China:experiences of different socio-economic groups[J].BMC Public Health,2007,7(2):19-20.
  • 2[2]Girard MP,Fruth U,Kieny MP.A review of vaccine research and development:tuberculosis[J].Vaccine,2005,23(50):5725-5731.
  • 3[3]Andersen CS,Dietrich J,Agger EM,et al.The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis[J].Infect Immun,2007,75(1):408-416.
  • 4[4]Sullivan BM,Jobe O,Lazarevic V,et al.Increased susceptibility of mice lacking T-bet to infection with Mycobacterium tuberculosis correlates with increased IL-10 and decreased IFN-gamma production[J].J Immunol,2005,175(7):4593-4602.
  • 5[5]Yu K,Mitchell C,Xing Y,et al.Toxicity of nitrogen oxides and related oxidants on mycobacteria:M.tuberculosis is resistant to peroxynitrite anion[J].Tuber Lung Dis,1999,79:191-198.
  • 6[6]Schluger NW.Recent advances in our understanding of human host responses to tuberculosis[J].Respir Res,2001,2(3):157-163.
  • 7[7]Kapina MA,Shepelkova GS,Mischenko VV,et al.CD27low CD4 T lymphocytes that accumulate in the mouse lungs during mycobacterial infection differentiate from CD27high precursors in situ,produce IFN-gamma,and protect the host against tuberculosis infection[J].J Immunol,200,178(2):976-985.
  • 8[8]Mustafa AS,Lundin KE,Meloen RH,et al.Identification of promiscuous epitopes from the Mycobacterial 65-kilodalton heat shock protein recognized by human CD4+ T cells of the Mycobacterium leprae memory repertoire[J].Infect Immun,1999,67(11):5683-5689.
  • 9[9]Gurunathan S,Klinman DM,Seder RA.DNA vaccines:immunology,application,and optimization[J].Annu Rev Immunol,2000,18(5):927-974.
  • 10[10]Chen L,Wang J,Zganiacz A,et al.Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis[J].Infect Immun,2004,72(1):238-246.

共引文献1

同被引文献38

  • 1黄涛,严华.黏膜免疫佐剂研究进展[J].微生物学免疫学进展,2007,35(4):55-60. 被引量:2
  • 2杨新超,赵祥颖,刘建军.壳聚糖的性质、生产及应用[J].食品与药品,2005,7(08A):59-62. 被引量:25
  • 3黄进,汪世龙,孙晓宇,李文哲,姚思德.壳聚糖及其衍生物基因载体的研究进展[J].高分子通报,2006(1):65-69. 被引量:15
  • 4赵雪,任慧霞.壳聚糖及其衍生物作为基因递送载体的研究进展[J].食品与药品,2006,8(02A):1-5. 被引量:4
  • 5Lu S,Wang S,Grimes-Serrano JM.Current progress of DNA vaccine studies in humans[J].Expert Rev Vaccines,2008,7(2):l75-191.
  • 6Neutra MR,Kozlowski PA.Mucosal vaccines:the promise and the challenge[J].Nat Rev Immunol,2006,6(2):148-158.
  • 7Yuki Y,Kiyono H.Mucosal vaccines:novel advances in technology and delivery[J].Expert Rev Vaccines,2009,8(8):1083-1097.
  • 8Chaves SS,Fischer G,Groeger J,et a1.Persistence of long-term immunity to hepatitis B among adolescents immunized at birth[J].Vaccine,2012,30(9):1644-1649.
  • 9Jiang H L,Kang M L,Quan J S,et al.The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization[J].Biomaterials,2008,29(12):1931-1939.
  • 10Jee J,Bonnegarde-Bernard A,Duverger A,et al.Neutrophils negatively regulate induction of mucosal IgA responses after sublingual immunization[J].Mucosal Immunol,2015,8(4):735-745.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部